Hiscox share price falls as Covid-19 losses rise to $232mn
Hiscox saw its share price fall almost five percent as the market opened today after it raised its Covid-19 loss estimate to $232mn and said its combined ratio had deteriorated 15.8 percentage points in H1 2020.
If you are a subscriber, please sign back in to read this article
If you are not currently a subscriber please see contact details below